The ECOG-ACRIN Cancer Research Group is a multidisciplinary, membership-based scientific organization that designs and conducts biomarker-driven cancer research involving adults who have or are at risk of developing cancer. Its network of member institutions is a core component of the Group and its three scientific programs: Cancer Control and Outcomes, Therapeutic Studies, and Biomarker Sciences.
The flexible structure of the ECOG-ACRIN membership program has resulted in a large network that provides substantial capabilities for the Group to carry out innovative research, whether in the form of a small focused study in a single center or a large-scale population-based trial across multiple institutions.
The ECOG-ACRIN member network comprises nearly 1100 participating institutions, including university schools of medicine, academic medical centers, National Cancer Institute-designated and other cancer centers, Lead Academic Participating Sites (LAPS), NCI Community Oncology Research Programs (NCORPs) and Minority and Underserved NCORPs (MU NCORPs), health systems, community hospitals, clinics, imaging practices, and physician practices. In addition to its predominant base of sites in the United States, ECOG-ACRIN is also represented in Australia, Brazil, Canada, China, Germany, Ireland, Israel, Japan, Peru, Puerto Rico, South Africa, South Korea, and Spain.
More than 12,000 individuals participate in ECOG-ACRIN through institutional membership. ECOG-ACRIN researchers and investigators have broad experience in clinical research disciplines and translational science. In clinical research, therapeutic and medical imaging disciplines include medical, surgical, and radiation oncology; hematology; radiology; nuclear medicine; internal medicine; and preventive medicine. In translational science, disciplines include laboratory-based pathology, genetics, molecular biology, and experimental imaging. Related disciplines include statistics, bioinformatics, clinical psychology and behavioral sciences, epidemiology, and health services.
|Scientific Planning and Review|
|Biostatistics and Data Management|
|Active Clinical Trials|